Anxiety and depression among women with newly diagnosed vulvar cancer - A nationwide longitudinal study.

ABSTRACT:

Introduction

Our objective was to investigate the trajectories of anxiety, depression, emotional and social functioning in women with newly diagnosed vulvar cancer from the time of diagnosis to 12 months after treatment. A further aim was to identify risk factors for high levels of anxiety.

Material and methods

PROVE (PROspective Vulvar Cancer Evaluation) is a nationwide longitudinal cohort study investigating quality of life in women with newly diagnosed vulvar cancer by the following validated patient-reported outcome measures at diagnosis, and 3 and 12 months after treatment: The Hospital Anxiety and Depression Scale, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30, and the European Organization for Research and Treatment o

SUBMITTER: Zach D 

PROVIDER: S-EPMC10823412 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature